Le Lézard
Classified in: Health, Science and technology
Subject: IPO

Karuna Therapeutics Files Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering


Karuna Therapeutics, Inc. today announced that it has previously confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The initial public offering is expected to commence after the SEC completes its review process, subject to market and other conditions.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended ("Securities Act"). This announcement is being issued in accordance with Rule 135 under the Securities Act.


These press releases may also interest you

at 14:29
iHealth Labs, Inc. (iHealth®), a leading provider of digital health solutions, today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the company's 3-in-1 COVID-19/Flu A&B Rapid Test Kit...

at 14:15
The CDC now estimates nearly half a million people will contract Lyme disease in the United States each year. However, most people do not realize how Lyme disease can cause diverse, devastating symptoms in some patients. The range of symptoms is...

at 14:15
Frederick, MD-based Genesis + HOCL introduces two HOCl atomizing machines for Air Quality Awareness Week. Genesis is the sole U.S. distributor of this technology, previously only available in Japan and South Korea, bringing the Genesis 2.6 and UX4 to...

at 14:09
The Independence Fund proudly presents "Beyond the Call" luncheon, a fundraising event dedicated to honoring and supporting the Caregivers of our nation's wounded Veterans. Join the event on May 16, 2024, at 11:00 AM at the Duke Mansion in Charlotte,...

at 14:05
Avicenna Biosciences today introduced an extension to its machine learning (ML) technology platform to enhance medicinal chemistry and expedite clinical-stage drug discovery. The company has raised $14.5 million in funding to date, with DCVC Bio...

at 14:00
Rendina Healthcare Real Estate is proud to announce the official opening of Inspira Health Center Deptford, a state-of-the-art outpatient health center in Deptford, NJ. This significant development is the result of a fruitful partnership with Inspira...



News published on and distributed by: